MedEdge MEA

FDA Approves Eli Lilly’s Zepbound™ for Obesity Treatment MedEdge MEA

INDIANAPOLIS: Eli Lilly and Company’s (NYSE: LLY) innovative obesity treatment, Zepbound™ (tirzepatide) injection, has received the green light from the U.S. Food and Dru...

Read More
UN Progress Report Highlights Efforts to Improve Lives of Older People MedEdge MEA

The World Health Organization (WHO) and UN partners have released the first progress report for the UN Decade of Healthy Ageing. The report highlights efforts to improve...

Read More
GE HealthCare Announces New Data Validating Artificial Intelligence Models MedEdge MEA

Chalfont St Giles, UK: GE HealthCare, Vanderbilt University Medical Center (VUMC), and the University Medicine Essen (UME), Germany, will present findings at the Society...

Read More
Menu
Categories
How does it work